Cannabinoids are increasingly being considered for the management of various painful conditions, and could be considered as an option for treating acute pain in sickle cell disease (SCD). The objective of this study was to determine the extent of use of cannabis in the community for pain and other symptom relief, and its side effects during self-administration in patients with SCD. Patients attending Central Middlesex Hospital in London were invited to complete a structured self-administered anonymous questionnaire. Eightysix young adults with HbSS, HbSC and HbSbthalassaemia disease (median age 30 years) participated in the study. Results showed that 31 (36%) had used cannabis in the...
Menu
